TPD52L2 and nonpapillary renal cell carcinoma: The expression level of TPD52L2 is positively correlated with the malignant clinical features, which also indicates that may play the role of a pathogenic gene in the pathological process of ccRCC and may also have a specific impact on patient diagnosis.